EPRXEupraxia Pharmaceuticals Inc. Common Stock
6.730USDMkt Cap: 443.55M $P/E: —3d ago
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug de…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap443.55M $
Enterprise Value339.65M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-38.58M $
Revenue/Share—
Last Price6.730 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees49
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.46
PEG—
EV/EBITDA-5.97
EV/Revenue—
P/S—
P/B4.33
EPS (TTM)-1.02
EPS (Forward)-1.04
52W Range
6.67930% of range6.850
52W High6.850 USD
52W Low6.679 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-47.02%
ROA-44.78%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.55M $
CapEx (TTM)588.95K $
FCF Margin—
FCF Yield-4.27%
Net Debt-131.82M $
Net Debt/EBITDA2.32
Balance Sheet
Debt/Equity0.00
Current Ratio16.00
Quick Ratio15.71
Book Value/Sh1.554 USD
Cash/Share2.028 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)16.35 USD
Upside (mean)+142.9%
Target Range11.00 USD – 25.00 USD
$11.00+142.9% to mean$25.00
# Analysts10
Ownership
Shares Out.65.91M
Float55.67M
Insiders14.22%
Institutions45.02%
Short Interest
Short Ratio16.6d
Short % Out.9.25%
Shares Short5.92M
Short (prev mo.)5.46M
Technical
SMA 506.488 (+3.7%)
SMA 2007.077 (-4.9%)
Beta1.50
S&P 52W Chg19.18%
Avg Vol (30d)297.26K
Avg Vol (10d)246.89K
Technical Indicators
RSI (14)53.1
MACD0.1012
MACD Signal0.0744
MACD Hist.+0.0268
BB Upper7.098 USD
BB Middle6.577 USD
BB Lower6.055 USD
BB Width15.87%
ATR (14)0.3365 USD
Vol Ratio (20d)0.81x